APPENDIX 2 Ailingnae Group and Control Mean Blood Counts by Day and by Age WBC (x10) Neutrophils («1079) Lymphocytes Platelets (x10") Monocytes (x 10-*) (x 10-7) Eosinophils (x 10°") Male Male Female Total Postexposure day <5 >5 <5 35 <5 35 <10 >10 allages group <5 >5 <5 >5 3 7 10 12 15 18 22 26 30 6.0 5.5 63 6.3 7.1 68 8.9 84 96 70 68 7.3 7.6 70 78 8.7 70 86 3.0 — 42 18 2.3 29 5.3 48 53 5.0 — 42 4.7 45 5.0 5.4 44 62 2.8 19 3.1 4.2 3.5 2.7 3.2 3.7 2.2 — 2.2 2.2 2.2 2.4 29 2.2 2.0 _— _ 22.5 _ 29.0 27.5 23.5 20.0 19.5 _ — 22.6 — 20.2 21.7 17.0 13.8 12.8 _ — 20.9 — 24.6 24.9 22.9 17.4 18.2 _ — 21.5 _— 23.9 24.3 21.3 16.7 16.8 0.8 -_ 38 3.4 3.7 2.3 15 2.3 19 1.6 = 2.1 5.8 26 1.5 24 2.4 619 05 _2.6 44 2.3 3.2 -3.8 0.6 4.1 0.4 = 1.6 26 La 23 24 16 20 39 43 47 51 7.5 6.9 7.3 8.4 6.2 65 6.7 6.3 2.9 2.7 3.5 3.8 4.2 3.6 3.8 3.6 4.7 39 3.4 40 19 27 27 2.2 26.5 28.0 27.0 32.0 20.8 19.6 20.0 18.2 27.0 25.3 26.1 25.0 25.2 24,0 24.5 23.9 11047 0.6 1.4 2.2 1.9 2.7 28 7.7 65 48 3.9 2.7 2.2 25.2 19.2 239 22.7 L.1 11.1 7.8 4.2 4.7 7.0 4.4 33 34 6-mo survev |-vr survey 7.7) 46 7.8 63 2-vr survey 3-vr survey 4-yr survey J-vr survey 6-vr survey Majuro controls 11.0 12.1 11.5 — 2 91 7.0 7.5 Yi 7.3 9.7 Rita controls. 2 vr 14.1 89 Rongelapcontrols, 3 vr Rongelapcontrols, 4 vr Rongelap controls, 3 vr 9.8 69 11.2 80 13.7 10.1 3.3 28 49 3.3 28 — — 48 40 40 6.2 5.2 3.5 5.1 3.9 37 3.1 3.6 48 34 3.6 3.2 3.5 32 6.5 48 3.6 7.0 — — 7400 5.6 4.7 6.2 62 ?.2 35 5.6 3.2 2.6 33 3.7 320 41 3.6 2.9 3.7 4.1 62 24.0 37.0) 38.7 51.2 40.8 33.2 40.9 — 41.2 33.5 32.6 38.8 35.8 15.8 19.8 21.4 17.4 22.4 24.7 26.3 — 25.8 24.2 26.9 30.7 28.0 22.7 23.8 17.6 24.2 28.3 27.5 31,2 29.5 26.4 31.2 33.6 20.8 — 36.5 30.0 34.0 33.6 26.7 — — — — 33.4 — — — 2.8 2.2 1.5 1.9 1.0 1.1 3.6 30 2.2 — — 20 i 14 2.30 3.7 14 Lt 07 1 3.2 O04 2.0 1.5 0.7 11 24 60 19 27 16 28 0.6 1.5° 07 2.2 1.0 18 O8 1.7 22 12.8 66 hoo 2 96 64 3.30037 1260 4.2 ~ 60 — 40 95 4.7 6.2 70° 6.2 4.0 435 6.0